Northwest Biotherapeutics, Inc. (BST:NBYB)
0.2100
0.00 (0.00%)
At close: Jan 15, 2026
Northwest Biotherapeutics Market Cap
Northwest Biotherapeutics has a market cap or net worth of €384.59 million as of January 16, 2026. Its market cap has increased by 11.15% in one year.
Market Cap
384.59M
Enterprise Value
458.58M
Revenue
798.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.21
Market Cap Chart
Since December 14, 2001, Northwest Biotherapeutics's market cap has increased from 11.37M to 384.59M, an increase of 3,281.10%. That is a compound annual growth rate of 15.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 15, 2026 | 384.59M | 26.00% |
| Dec 31, 2025 | 305.24M | -13.17% |
| Dec 31, 2024 | 351.54M | -52.72% |
| Dec 29, 2023 | 743.52M | -4.28% |
| Dec 30, 2022 | 776.73M | 33.17% |
| Dec 31, 2021 | 583.27M | -43.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 239.73B |
| Siemens Aktiengesellschaft | 201.29B |
| Allianz SE | 143.50B |
| Deutsche Telekom AG | 133.62B |
| Siemens Energy AG | 108.54B |
| Rheinmetall AG | 87.36B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.57B |
| Deutsche Bank Aktiengesellschaft | 64.16B |